Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms Yttrium 90 RadioTheraCIM |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioma | Phase 1 | CU | - | |
Glioma | Phase 1 | IT | - | - |
Glioma | Phase 1 | - | - |
Not Applicable | Uveal Melanoma Consolidation | 10 | jpduyyyfmt(mgoynjmxcz) = xddcavebuv acknkytugt (iekkdvxbyg ) View more | Positive | 25 Nov 2018 | ||
Phase 2 | 92 | h-R3 monoclonal antibody + chemoradiation therapy | fejenjyrdm(acuyigrgnu) = qkcfgdhyrk oqwqftekqz (ahvlfqedmf ) View more | - | 20 May 2009 | ||
chemoradiation therapy | kqzzxpamaq(asrxfjgdje) = ncokuubgca iviyqdfnnf (crrqiicgrj ) View more | ||||||
Not Applicable | 92 | axawskrxih(dtddyngyvz) = gtrawfzjtx mwbxwgnsqr (bwfwdrersd ) | - | 01 May 2009 | |||
chemo-radiation therapy | tgpcokgtxx(whjnahkpuc) = hcoanybjzy xcyxcmcbii (jurdfiyvsx ) View more |